119 related articles for article (PubMed ID: 11184997)
1. Neuroscience. Pesticide causes Parkinson's in rats.
Helmuth L
Science; 2000 Nov; 290(5494):1068. PubMed ID: 11184997
[No Abstract] [Full Text] [Related]
2. Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease.
Höglinger GU; Carrard G; Michel PP; Medja F; Lombès A; Ruberg M; Friguet B; Hirsch EC
J Neurochem; 2003 Sep; 86(5):1297-307. PubMed ID: 12911637
[TBL] [Abstract][Full Text] [Related]
3. Chronic systemic pesticide exposure reproduces features of Parkinson's disease.
Betarbet R; Sherer TB; MacKenzie G; Garcia-Osuna M; Panov AV; Greenamyre JT
Nat Neurosci; 2000 Dec; 3(12):1301-6. PubMed ID: 11100151
[TBL] [Abstract][Full Text] [Related]
4. The rotenone model of Parkinson's disease.
Perier C; Bové J; Vila M; Przedborski S
Trends Neurosci; 2003 Jul; 26(7):345-6. PubMed ID: 12850429
[No Abstract] [Full Text] [Related]
5. Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models.
Takeuchi H; Yanagida T; Inden M; Takata K; Kitamura Y; Yamakawa K; Sawada H; Izumi Y; Yamamoto N; Kihara T; Uemura K; Inoue H; Taniguchi T; Akaike A; Takahashi R; Shimohama S
J Neurosci Res; 2009 Feb; 87(2):576-85. PubMed ID: 18803299
[TBL] [Abstract][Full Text] [Related]
6. Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system.
Betarbet R; Canet-Aviles RM; Sherer TB; Mastroberardino PG; McLendon C; Kim JH; Lund S; Na HM; Taylor G; Bence NF; Kopito R; Seo BB; Yagi T; Yagi A; Klinefelter G; Cookson MR; Greenamyre JT
Neurobiol Dis; 2006 May; 22(2):404-20. PubMed ID: 16439141
[TBL] [Abstract][Full Text] [Related]
7. Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson's disease in rats.
Karuppagounder SS; Madathil SK; Pandey M; Haobam R; Rajamma U; Mohanakumar KP
Neuroscience; 2013 Apr; 236():136-48. PubMed ID: 23357119
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of a novel model of Parkinson's disease by intra-striatal infusion of the pesticide rotenone.
Mulcahy P; Walsh S; Paucard A; Rea K; Dowd E
Neuroscience; 2011 May; 181():234-42. PubMed ID: 21277943
[TBL] [Abstract][Full Text] [Related]
9. Divergent mechanisms of paraquat, MPP+, and rotenone toxicity: oxidation of thioredoxin and caspase-3 activation.
Ramachandiran S; Hansen JM; Jones DP; Richardson JR; Miller GW
Toxicol Sci; 2007 Jan; 95(1):163-71. PubMed ID: 17018646
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of toxicity in rotenone models of Parkinson's disease.
Sherer TB; Betarbet R; Testa CM; Seo BB; Richardson JR; Kim JH; Miller GW; Yagi T; Matsuno-Yagi A; Greenamyre JT
J Neurosci; 2003 Nov; 23(34):10756-64. PubMed ID: 14645467
[TBL] [Abstract][Full Text] [Related]
11. Sodium salicylate protects against rotenone-induced parkinsonism in rats.
Madathil SK; Karuppagounder SS; Mohanakumar KP
Synapse; 2013 Aug; 67(8):502-14. PubMed ID: 23447126
[TBL] [Abstract][Full Text] [Related]
12. Rotenone, deguelin, their metabolites, and the rat model of Parkinson's disease.
Caboni P; Sherer TB; Zhang N; Taylor G; Na HM; Greenamyre JT; Casida JE
Chem Res Toxicol; 2004 Nov; 17(11):1540-8. PubMed ID: 15540952
[TBL] [Abstract][Full Text] [Related]
13. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
[TBL] [Abstract][Full Text] [Related]
14. Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster.
Coulom H; Birman S
J Neurosci; 2004 Dec; 24(48):10993-8. PubMed ID: 15574749
[TBL] [Abstract][Full Text] [Related]
15. Glyceraldehyde-3-phosphate dehydrogenase: activity inhibition and protein overexpression in rotenone models for Parkinson's disease.
Huang J; Xiong N; Chen C; Xiong J; Jia M; Zhang Z; Cao X; Liang Z; Sun S; Lin Z; Wang T
Neuroscience; 2011 Sep; 192():598-608. PubMed ID: 21736921
[TBL] [Abstract][Full Text] [Related]
16. Dopamine oxidation facilitates rotenone-dependent potentiation of N-methyl-D-aspartate currents in rat substantia nigra dopamine neurons.
Wu YN; Johnson SW
Neuroscience; 2011 Nov; 195():138-44. PubMed ID: 21884756
[TBL] [Abstract][Full Text] [Related]
17. Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of Parkinson's disease.
Carriere CH; Kang NH; Niles LP
Brain Res; 2016 Feb; 1633():115-125. PubMed ID: 26740407
[TBL] [Abstract][Full Text] [Related]
18. Docosahexaenoic acid protection in a rotenone induced Parkinson's model: Prevention of tubulin and synaptophysin loss, but no association with mitochondrial function.
Serrano-García N; Fernández-Valverde F; Luis-Garcia ER; Granados-Rojas L; Juárez-Zepeda TE; Orozco-Suárez SA; Pedraza-Chaverri J; Orozco-Ibarra M; Jiménez-Anguiano A
Neurochem Int; 2018 Dec; 121():26-37. PubMed ID: 30342962
[TBL] [Abstract][Full Text] [Related]
19. Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine.
Nehru B; Verma R; Khanna P; Sharma SK
Brain Res; 2008 Mar; 1201():122-7. PubMed ID: 18308296
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D₁ and D₂ receptor subtypes functional regulation in cerebral cortex of unilateral rotenone lesioned Parkinson's rat model: Effect of serotonin, dopamine and norepinephrine.
Paul J; Kuruvilla KP; Mathew J; Kumar P; Paulose CS
Parkinsonism Relat Disord; 2011 May; 17(4):255-9. PubMed ID: 21306935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
